Should we be concerned about direct-to-consumer advertising of prescription drugs?

Journal of Bioethical Inquiry 2 (2):61-62 (2005)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,072

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Journal of bioethical inquiry: Reviewing policy. [REVIEW]Ian Kerridge - 2008 - Journal of Bioethical Inquiry 5 (1):93-99.
Editorial.Ian Kerridge & Paul A. Komesaroff - 2008 - Journal of Bioethical Inquiry 5 (1):1-1.
Correction.Grant Gillett - 2005 - Journal of Bioethical Inquiry 2 (2):62-62.
Response.Grant Gillett - 2010 - Journal of Bioethical Inquiry 7 (2):271-272.
Response.Jon Jureidini - 2006 - Journal of Bioethical Inquiry 3 (3):195-196.
Response.Louise Newman - 2006 - Journal of Bioethical Inquiry 3 (3):197-198.
Response.Christoph Rehmann-Sutter - 2010 - Journal of Bioethical Inquiry 7 (1):135-136.

Analytics

Added to PP
2009-01-28

Downloads
39 (#578,130)

6 months
5 (#1,043,573)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references